NCT03784976

Brief Summary

The purpose of this clinical trial is to look at the effectiveness of prescribing yoga classes to patients with dysmenorrhea (irregular or painful periods), or other menstrual disorders on patients' self reported pain and quality of life. Patients will be recruited from primary care clinics around Illinois, including Carle Hospital. This is a randomized trial in which patients will first be randomized into the control or intervention group. Patients in the control group will undergo usual care and be surveyed at baseline, 3 months, 6 months and 9 months. Patients in the control group will be offered the 3 months of yoga therapy complimentary after completing the 9 month control. Control patients who choose to participate in the yoga therapy will be asked to also complete the surveys at the end of the 3 month yoga intervention. Patients in the intervention group will first undergo 3 months of regular care and then 3 months of biweekly yoga classes. Participants will complete surveys at baseline, 3 months (after of control care), 6 months (after 3 months of biweekly yoga classes), 9 months, and 12 months (after 6 months of observation and optional yoga practice).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2021

Completed
Last Updated

December 24, 2018

Status Verified

December 1, 2018

Enrollment Period

3 years

First QC Date

September 11, 2018

Last Update Submit

December 20, 2018

Conditions

Outcome Measures

Primary Outcomes (7)

  • NIH PROMIS Pain Interference Survey

    This survey is a 4 question short form. The PROMIS(r) Pain Interference instruments (adult and child) measure the self-reported consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities.

    baseline, 3 months, 6 months, 9 months, 12 months

  • NIH PROMIS Pain Intensity Survey

    This survey is a 3 question short form. The PROMIS Pain Intensity instrument assesses how much a person hurts.

    baseline, 3 months, 6 months, 9 months, 12 months

  • NIH PROMIS Fatigue Survey

    This survey is a 4 question short form. The PROMIS Fatigue instruments evaluate a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social roles.

    baseline, 3 months, 6 months, 9 months, 12 months

  • NIH PROMIS Physical Function Survey

    This survey is a 4 question short form. Physical Function measures self-reported capability rather than actual performance of physical activities. This includes the functioning of one's upper extremities (dexterity), lower extremities (walking or mobility), and central regions (neck, back), as well as instrumental activities of daily living, such as running errands.

    baseline, 3 months, 6 months, 9 months, 12 months

  • NIH PROMIS Global Health Scale

    This survey is a 7 question short form. The PROMIS Global Health measures assess an individual's physical, mental, and social health.

    baseline, 3 months, 6 months, 9 months, 12 months

  • Self-Reported Home Practice survey

    This survey is a 10 question survey about participants home yoga practice.

    baseline, 3 months, 6 months, 9 months, 12 months

  • Menstrual Distress Questionnaire

    The Menstrual Distress Questionnaire (MDQ) is a standard method for measuring cyclical perimenstrual symptoms. It is used to help clinicians and researchers make systematic, empirical evaluations of a woman's symptoms, of treatments, and of etiological theories. The MDQ is a 46-item self-report inventory for use in the assessment and treatment of premenstrual and menstrual symptoms.

    baseline, 3 months, 6 months, 9 months, 12 months

Study Arms (2)

Intervention

EXPERIMENTAL

Patients in the intervention group will first undergo 3 months of regular care and then 3 months of biweekly yoga classes. Participants will complete surveys at baseline, 3 months (after of control care), 6 months (after 3 months of biweekly yoga classes), and 12 months (after 6 months of observation and optional yoga practice).

Other: Iyengar Yoga Therapy

Control

NO INTERVENTION

The study lasts 12 months for the intervention and 9 months for the control group with an optional 3 month yoga therapy session offered at the end

Interventions

2 weekly yoga class (1.25 hours each)

Also known as: Iyengar Yoga
Intervention

Eligibility Criteria

Age12 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsMust menstruate or be of menstruating age
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iyengar Yoga Center

Urbana, Illinois, 61801, United States

RECRUITING

MeSH Terms

Conditions

DysmenorrheaPolycystic Ovary SyndromeEndometriosisLeiomyomaMenstruation Disturbances

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and SymptomsOvarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesNeoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic Type

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 11, 2018

First Posted

December 24, 2018

Study Start

July 3, 2018

Primary Completion

July 2, 2021

Study Completion

July 2, 2021

Last Updated

December 24, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations